I have over 20 years experience in the pharmaceutical industry, spanning early and late-stage discovery research and preclinical development. I have held senior roles at Shire, AstraZeneca and Merck and was one of the founders of Polleo Pharma.
Prior to co-founding Polleo Pharma, I was a Director within the Exploratory Projects Department for Shire Speciality Pharmaceuticals in the UK. I carried out post-doctoral research at Novo Nordisk.
I hold a PhD in Biochemistry from Imperial College London, an MSc in Toxicology from the Royal Postgraduate Medical School, London and a BSc in Pharmacology/Physiology from the University of Leeds.